Ki67 and proliferation in breast cancer (Q38084286)

28 August 2017

title

Ki67 and proliferation in breast cancer (English)

1 reference

28 August 2017

1 reference

2

Rosemary L Balleine

1 reference

28 August 2017

Nirmala Pathmanathan

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

22 February 2013

1 reference

Journal of Clinical Pathology

28 August 2017

published in

1 reference

28 August 2017

volume

66

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

512-516

1 reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Independent prognostic value of screen detection in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Is adjuvant chemotherapy useful for women with luminal a breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Proliferation marker Ki-67 in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Diagnostic evaluation of papillary lesions of the breast on core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

Molecular Grading of Ductal Carcinoma In situ of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1136/JCLINPATH-2012-201085

10.1136/JCLINPATH-2012-201085

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference